about
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective surveyValidation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis.Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.ESPEN Guidelines on Enteral Nutrition: Liver disease.Malnutrition is a risk factor in cirrhotic patients undergoing surgery.The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice.Dietary and nutritional indications in hepatic encephalopathy.Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis.Nutritional status and liver transplantation.Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?Small hepatic veins Budd-Chiari syndrome.Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee.Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.Fatty acid composition of adipose tissue in patients with chronic liver disease.A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.Total and individual free fatty acid concentrations in liver cirrhosis.Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.Increased nonoxidative glucose metabolism in idiopathic reactive hypoglycemia.Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis.Drug therapy: rifaximin.Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy.Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin- and downregulation of hemojuvelin- and Fpn-1-gene expression in murine liver.Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patients.Improving the inhibitory control task to detect minimal hepatic encephalopathy.Incidence and natural history of small esophageal varices in cirrhotic patients.Do we really need alternatives to polymorphonuclear cells counting in ascitic fluid?Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: a retrospective case-control study.The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension.Reply: To PMID 23707462.Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial.Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients.Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease.Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients.Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis.Aminoacid imbalance and malnutrition in liver cirrhosis.
P50
Q28547409-2FC8B643-BA05-410E-84C4-D51A4C2A156FQ31153082-662D73EE-0CB4-4CDC-BFAD-CC5CDF127125Q34278911-C64E1E57-13D1-474B-BBFD-879A5F9F0AE3Q34527391-66AD0914-E5E1-4B1C-B602-C92A062653C5Q34996959-7B8CD24A-4113-4F7D-B85C-F7CCD5BF0799Q35170336-A47ABB97-7C45-4ED2-AD1D-0DDA48DAFAC0Q37257812-7AEFE88E-D422-4B17-B0DA-2E9F75869A5EQ37340345-151D1706-F0BE-45BF-9AAB-BC880DCB8A7EQ37356439-53EC218A-C7A6-4843-B579-4A36FAD7758AQ37613643-A5280AC4-7BED-4AC3-8646-647F3CCB1B35Q37663080-C29D872B-FEEA-46EB-8101-090F3E3670F3Q37699648-7E19F192-A1D9-4BE6-B287-A46513C34AE6Q37706062-48E8ADCA-B355-4EE6-BE7E-FB228D887730Q37824068-7E3AC949-49CF-45A5-B845-A81D0C777462Q37982869-D00FDD06-92F4-43DD-8FD5-40F1260612ADQ41472579-58DB3174-158D-4C65-AF1F-230AC171A53AQ41554599-B609FCB5-60CE-43F4-95BE-CB28B9485284Q41596933-0781FF37-053C-4E43-8BE7-2348CF74CB1DQ42269672-945F5932-96CD-4F35-AC9F-B8D98947A944Q42517148-4F068F18-7E9C-4324-8874-B8EE2CD09125Q42689940-65045F7D-88A6-4917-97A0-7D9737477539Q42918540-D950015B-0459-449E-85AE-395CFC8D830CQ43177106-A48CC1D0-3532-4F5D-A162-E87517CF5EB9Q43282755-E57D7EA1-2F1F-4B7B-B2DB-6159918EB15BQ43877225-95FA87D0-0844-48B7-AA79-00D4F40A10FDQ44325957-0C2D03B6-1C01-4B29-8561-09CC1BC8707AQ44327220-CDF38D1D-BD01-40CC-AB15-EF66D0568783Q44370094-C14C8069-43B2-49B5-9A9A-30593A284035Q44547783-37AFA641-1582-47A1-9CD6-F0514C2796D5Q44693272-25837613-7C0D-47FF-8885-17072D5F274DQ44775026-8931CF1F-6E1A-4D16-B9DD-29744540D7B0Q44992650-7F45C89B-1569-49B5-9C58-9FB25E352E06Q45310078-527CF5E5-558D-45A2-9B66-993DF3B02CBDQ45720090-12A47F80-72EC-44FF-8981-5B2B6C8D0CABQ45982442-C708A9B8-A3A4-483B-AE7B-0D1EDBF9A31CQ46237348-AE82F32B-3F38-4EC3-B75E-0683335E1BDAQ46385914-CB146048-2D7B-4339-9A23-E9044DD05871Q46434785-651AEE8C-A644-482A-AEAA-C5E8F2730E17Q46909629-B483ABA4-138B-449F-99F8-3944049C1CBBQ47904888-1B8E0250-22F4-40B5-88EA-D29906BA87DD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Oliviero Riggio
@ast
Oliviero Riggio
@en
Oliviero Riggio
@es
Oliviero Riggio
@nl
Oliviero Riggio
@sl
type
label
Oliviero Riggio
@ast
Oliviero Riggio
@en
Oliviero Riggio
@es
Oliviero Riggio
@nl
Oliviero Riggio
@sl
prefLabel
Oliviero Riggio
@ast
Oliviero Riggio
@en
Oliviero Riggio
@es
Oliviero Riggio
@nl
Oliviero Riggio
@sl
P106
P1153
7006488883
P21
P31
P496
0000-0003-0241-3223